CSIMarket

Abbott Laboratories  (ABT)
Other Ticker:  
 
 

Abbott Laboratories Growth Comparisons

Select each growth Category to receive further Information



ABT Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 13.76% 19.44% 13.74% 14.49%
Q / Q Revenue Growth (Q1 MRQ) 3.72% 0.55% -0.28% -3.08%
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 19.22% 30.11% 20.31% %
Seq. Revenue Growth (for 12 months ending Q1 TTM) 3.34% 4.3% 2.95% 3.32%
Revenue 5 Year Average Growth 15.61% 16.67% 10.14% 12%


ABT's Growth Comparisons in the I. Quarter 2022




Abbott Laboratories's 13.76% year on year Revenue increase in the first quarter 2022 to 11.90 billions, marks slow-down from Abbott Laboratories's growth trends, and competes unfavorably to the 19.44% rise in the Major Pharmaceutical Preparations industry, but beating the 13.74% improvement in the Healthcare sector. Comparing the first quarter sales, Abbott Laboratories was trailing overall market not just the Major Pharmaceutical Preparations industry.

Comparing the company's Revenue to the forth quarter results, sales were higher by 3.72% . On the yearly basis, average annual sales growth for Abbott Laboratories is 15.61%, while S & P 500's including only Businesses with the first quarter 2022 earnings, average annual sales growth is 12% over the past five years.


Growth Rates of ABT's Income in the first quarter 2022


ABT Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) 38.07% 51.38% 0.42% 11.63%
Seq. Operating Income Change (Q1 MRQ) 22.46% 62.58% -12.52% -11.7%
Y / Y Operating Income Growth (Q1 TTM) 37.57% 146.91% 78.33% 66.76%
Seq. Operating Income Growth (Q1 TTM) 9.53% 11.78% 1.14% 3.13%
Operating Income 5 Year Avg. Change 21.48% 21.24% 9.98% 17.25%


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) 36.48% 27.75% -27.09% 3.01%
Seq. Income from Cont. Ops. Change (Q1 MRQ) 23.03% 27.99% -41.35% -8.98%
Y / Y Income from Cont. Ops. Change (Q1 TTM) 35.05% 156.47% 119% 71.73%
Seq. Income from Cont. Ops. Change (Q1 TTM) 9.25% 6.23% -4.86% 0.94%
Income from Cont. Ops. 5 Year Avg. Change 57.66% 39.7% 19.26% 20.08%

ABT Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) 36.48% 27.3% -27.71% 4.63%
Q / Q Net Income Growth (Q1 MRQ) 23.03% 28.78% -41.04% -8%
Y / Y Net Income Change (Q1 TTM) 34.96% 154.59% 126.4% 76.19%
Seq. Net Income Change (Q1 TTM) 9.25% 6.14% -4.92% 1.28%
Net Income 5 Year Avg. Growth 38.25% 39.36% 19.51% 20.28%

ABT's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) 38% 27.09% -27.09% 3.01%
Seq. EPS from Cont. Ops. Change (Q1 MRQ) 23.21% 42.16% -41.35% -8.98%
Y / Y EPS from Cont. Ops. Change (Q1 TTM) 35.62% - - -
Seq. EPS from Cont. Ops. Change (Q1 TTM) 9.57% - - 8433.49%
EPS from Cont. Ops. 5 Year Avg. Growth 41.09% 52.61% 19.26% 20.08%



ABT EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) 37% 26.65% -27.71% 20.08%
Q / Q EPS Net Growth (Q1 MRQ) 22.76% 43.03% -41.04% -8%
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 62960.9%
Seq. EPS Net Change (for 12 months ending Q1 TTM) 9.38% - - 55.47%
EPS Net 5 Year Avg. Change 33.19% 39.36% 19.51% 20.28%
Expected EPS Growth (Y/Y) -59.39% - 123.59% 20.77%



With 37% year on year EPS increase in the first quarter, Abbott Laboratories outperformed the 26.65% improvement in the Major Pharmaceutical Preparations industry, and -27.71% cut in the Healthcare sector. Comparing the first quarter income per share growth, both Major Pharmaceutical Preparations industry and Abbott Laboratories outperformed 4.63% overall market increase.

The company's sequential bottom-line increase was 22.76% from the forth quarter. Average annual income per share rise for Abbott Laboratories is 33.19%, while S & P 500's average yearly income per share growth is 20.28% over the five years, including only Businesses with the first quarter 2022 earnings results.

ABT Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) -21.69% 30.66% -15.64% 2.9%
Seq. Free Cash Flow Change (Q1 MRQ) -32.67% -10.09% -33.86% -66.7%
Y / Y Free Cash Flow Change (Q1 TTM) 1.4% 26.5% 11.71% 49.69%
Seq. Free Cash Flow Change (Q1 TTM) -5.43% 4.72% 0.39% -0.9%
Free Cash Flow 5 Year Avg. Change 32.95% 30.54% 19.28% 25.19%

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - - -
Seq. Net Cash Flow Change (Q1 MRQ) - - - -
Y / Y Net Cash Flow Change (Q1 TTM) - -53.64% - -79.9%
Seq. Net Cash Flow Change (Q1 TTM) - -63.3% - -52.34%
Net Cash Flow 5 Year Avg. Change -26.3% 46.3% 50.36% 123.83%

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) -19.14% 4.65% 6.22% 14.65%
Seq. Capital Expenditures Change (Q1 MRQ) -47.72% -27.19% -33.24% -39.15%
Y / Y Capital Expenditures Change (Q1 TTM) -18.29% -2.58% 11.68% 21.13%
Seq. Capital Expenditures Change (Q1 TTM) -4.03% 1.83% 2.76% 2.95%
Capital Expenditures 5 Year Avg. Change - 461.7% 159.14% 81.16%

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 





       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NMR's Profile

Stock Price

NMR's Financials

Business Description

Fundamentals

Charts & Quotes

NMR's News

Suppliers

NMR's Competitors

Customers & Markets

Economic Indicators

NMR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071